← Back to Merkel Cell Carcinoma

Why Sentinel Lymph Node Biopsy Is Routine for Merkel Cell Carcinoma

Checking the lymph nodes even when they feel normal

Medically reviewed by Dr. Steven Q. Wang, MDLast reviewed

Bring a printable list of questions to your appointment, or share this page with someone who needs it.

Download printable checklist (PDF)

Introduction

For most skin cancers, a doctor feels the nearby lymph nodes and, if they seem normal, moves on. Merkel cell carcinoma (MCC) is different. It reaches the lymph nodes early and quietly, and roughly a third of people whose nodes feel completely normal turn out to have cancer cells hiding in them. That is why a sentinel lymph node biopsy (SLNB) is a standard part of the MCC work-up, not an optional add-on.

This guide explains what the sentinel node is, how the biopsy is done, and how the result reshapes staging and treatment.

Have Questions?

Ask questions and get clear, trusted answers — instantly.

Chat with the Navigator

What Is the Sentinel Node?

Lymph fluid from any patch of skin drains first to one or a few specific "sentinel" lymph nodes before reaching the rest of the basin. If MCC cells have begun to spread through the lymphatic system, the sentinel node is where they show up first. Finding cancer there — or confirming it is clear — is the most accurate way to know whether the disease is still confined to the skin.

This matters because MCC understages easily on exam and imaging alone. In large datasets that informed the current AJCC staging system, pathologic node status was one of the strongest predictors of outcome — a distinction only a biopsy can make.

How the Biopsy Is Done

1. Mapping

A small amount of radioactive tracer, and sometimes a blue dye, is injected around the tumor site. Over the next hour or so, imaging (lymphoscintigraphy) or a handheld probe shows which node(s) the tracer travels to.

2. Removal

Under the same anesthesia used to widely remove the skin tumor, the surgeon makes a small incision over the sentinel node(s) and removes them. This is usually done before the tumor area is reconstructed, because earlier surgery in the region can scramble the drainage pattern and make the test unreliable.

3. Pathology

The nodes are examined with the same immunostains used on the primary tumor (such as CK20), which can reveal even a handful of cancer cells that routine staining would miss. Results typically take several days.

What the Result Means

  • •Negative sentinel node: No cancer detected in the nodes. The disease is pathologically confined to the skin (Stage I–II), the outlook is more favorable, and treatment focuses on the primary site — often surgery with or without radiation. Nodal radiation can usually be avoided.
  • •Positive sentinel node: The cancer is at least Stage III. The lymph node basin is then treated with radiation, surgical removal of the nodes (completion lymph node dissection), or both, and medical oncology is typically involved to discuss further therapy or a trial.
  • •When SLNB may be skipped: If nodes are already known to contain cancer, if distant metastases are present, or occasionally when frailty or tumor location makes the procedure impractical. Your team weighs these individually.

See how node status fits into the larger picture in diagnosis and staging.

What to Ask Your Doctor

Download printable checklist (PDF)
  1. Will my sentinel lymph node biopsy be done at the same time as the wide excision?
  2. Who reads the node pathology, and are MCC-specific immunostains used?
  3. If the node is positive, will you recommend radiation, surgery to remove the nodes, or both?
  4. What are the risks of the procedure for me — lymphedema, numbness, seroma, wound issues?
  5. If a biopsy is not recommended in my case, what is the reason, and how will you monitor the nodes instead?

Conclusion

A sentinel lymph node biopsy is routine in MCC because the disease spreads to lymph nodes far more often, and far more silently, than its size or a physical exam suggests. The result either provides genuine reassurance that the cancer is skin-confined or triggers earlier, more effective treatment of the lymph node basin.

If a biopsy is offered, ask how and when it will be done; if it is not, ask why. Either way, node status will shape the rest of your plan.

Sources

Clinical Guidelines & Peer-Reviewed Literature

  • Gupta SG, Wang LC, Peñas PF, et al. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol. 2006;142(6):685-690. PubMed
  • Harms KL, Healy MA, Nghiem P, et al. Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System. Ann Surg Oncol. 2016;23(11):3564-3571. PubMed
  • Coggshall K, Tello TL, North JP, Yu SS. Merkel cell carcinoma: An update and review: Pathogenesis, diagnosis, and staging. J Am Acad Dermatol. 2018;78(3):433-442. PubMed
  • Bichakjian CK, Olencki T, Aasi SZ, et al. Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(6):742-774. PubMed

Patient Resources

Disclaimer: Educational only. Not a substitute for professional medical advice. Always consult your dermatologist or oncologist about your personal diagnosis and treatment plan.

Still Have Questions?

Chat with our AI guide for personalized information about Merkel cell carcinoma

Chat with the Navigator